Shopping Cart
- Remove All
- Your shopping cart is currently empty
PROTAC PARP1 degrader-4 (Compound 180055) is a selective PARP1 PROTAC degrader, demonstrating DC50 values of 180 nM and 240 nM in T47D and MDA-MB-231 cell lines, respectively. It facilitates the ubiquitination and degradation of PARP1 and inhibits its enzymatic activity without causing significant DNA trapping effects. Additionally, PROTAC PARP1 degrader-4 can inhibit tumors with BRCA gene mutations while having minimal impact on the growth of normal cells.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | PROTAC PARP1 degrader-4 (Compound 180055) is a selective PARP1 PROTAC degrader, demonstrating DC50 values of 180 nM and 240 nM in T47D and MDA-MB-231 cell lines, respectively. It facilitates the ubiquitination and degradation of PARP1 and inhibits its enzymatic activity without causing significant DNA trapping effects. Additionally, PROTAC PARP1 degrader-4 can inhibit tumors with BRCA gene mutations while having minimal impact on the growth of normal cells. |
In vitro | PROTAC PARP1 degrader-4 (1-10 μM, 24-48 h) shields T47D and MOLT4 cells from cell death induced by genotoxic stress [1]. Additionally, PROTAC PARP1 degrader-4 (10 μM, 3-6 days) induces cytotoxic effects in BRCA1-mutated MOLT4 cells [1]. |
In vivo | PROTAC PARP1 degrader-4 (40 mg/kg, intraperitoneal injection, 16 days) exhibits antitumor activity against MOLT4 xenograft mice with BRCA1 mutations [1]. |
Molecular Weight | 920.145 |
Formula | C51H62FN7O6S |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice./Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.